GSN and breast carcinoma: Importantly, elevated levels of gelsolin expression have been detected in human non-small cell lung [69], colorectal [70], and pancreatic carcinomas [71] and depletion of gelsolin using siRNAs in pancreatic, prostate, colorectal, and breast carcinoma cell lines caused a marked reduction in cell motility [72].